Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: A randomized, double-blind, placebo-controlled trial

Published:2009-04 Issue:4 Volume:60 Page:1102-1111
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Khanna Dinesh,Clements Philip J.,Furst Daniel E.,Korn Joseph H.,Ellman Michael,Rothfield Naomi,Wigley Fredrick M.,Moreland Larry W.,Silver Richard,Kim Youn H.,Steen Virginia D.,Firestein Gary S.,Kavanaugh Arthur F.,Weisman Michael,Mayes Maureen D.,Collier David,Csuka Mary E.,Simms Robert,Merkel Peter A.,Medsger Thomas A.,Sanders Martin E.,Maranian Paul,Seibold James R.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24380/fullpdf

Reference28 articles.

1. Relaxin in cardiovascular and renal disease;Samuel;Kidney Int,2006

2. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts;Unemori;J Biol Chem,1990

3. Relaxin alone and in conjunction with interferon-γ decreases collagen synthesis by cultured human scleroderma fibroblasts;Unemori;J Invest Dermatol,1992

4. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis;Unemori;J Invest Dermatol,1993

5. Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial;Seibold;Ann Intern Med,2000

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First‐in‐Human, Randomized, Single‐Blind, Placebo‐Controlled Study;Journal of the American Heart Association;2024-08-06

2. Relaxin as a treatment for musculoskeletal fibrosis: What we know and future directions;Biochemical Pharmacology;2024-07

3. Understanding fibrosis: Mechanisms, clinical implications, current therapies, and prospects for future interventions;Biomedical Engineering Advances;2024-06

4. Periodic injections of Relaxin 2, its pharmacokinetics and remodeling of rat hearts;Biochemical Pharmacology;2024-05

5. The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin;Biochemical Pharmacology;2024-05